Experts say the exploitation of a loophole in the patent system has contributed to high prices for inhalers.
https://siii-clinical.com/wp-content/uploads/2021/09/Untitled-1.png00https://siii-clinical.com/wp-content/uploads/2021/09/Untitled-1.png2023-09-14 17:46:292023-09-14 17:46:29Common Patenting Tactic by Drug Companies May Be Illegal, F.T.C. Says
From research laboratories to clinical settings, SIII integrates the technologies, resources, and expertise our customers need to rise to the next opportunity. SIII is dedicated to exploring and researching the processes and scientific mechanisms underlying the world we live in.